OSUR · Orasure Technologies Inc
$3.84
-0.18 (-4.48%)
At close · Aug 14
Market Cap
$258.63M
Shares
68.97M
Orasure Technologies Inc Earnings Call Transcripts
Every quarterly earnings call for Orasure Technologies Inc (OSUR) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲116%
$116.46M
$5.59M
'22 Q3
22-11-08
▲93.6%
$123.08M
−$31.36M
'22 Q4
23-02-14
▲128.9%
$154.96M
$27.22M
'23 Q1
23-05-10
▲6.5%
$85.44M
−$4.80M
'23 Q2
23-08-03
▼23.4%
$89.19M
$11.16M
'23 Q3
23-11-07
▼38.3%
$75.88M
$20.07M
'23 Q4
24-02-27
▼65.1%
$54.13M
−$3.58M
'24 Q1
24-05-08
▼36.4%
$54.34M
−$615,000
'24 Q2
24-08-06
▼55.2%
$39.91M
−$4.51M
'24 Q3
24-11-06
▼50.7%
$37.45M
−$10.79M
'24 Q4
25-02-25
▼44.7%
$29.93M
−$16.04M
'25 Q1
25-05-07
▼42.5%
$31.24M
−$19.69M
'25 Q2
25-08-05
▼32.1%
$27.09M
−$13.71M
'25 Q3
25-11-05
▼28.5%
$26.76M
−$19.29M
'25 Q4
26-02-25
▼6.7%
$27.93M
−$22.38M
'26 Q1
26-05-06
LATEST
▼1.9%
$30.64M
$6.25M
'26 Q2
26-08-05
Earnings call
FY26 · Q2
2026-08-05
Orasure Technologies Inc Q2 FY2026 Earnings Call
Positive tone
COLE-PDX / ColiP-DX STI product launch
IntelliQuick CTNG FDA delay
Revenue performance and guidance
Revenue
$30.64M
▼ 1.9% YoY Diluted EPS
$0.09
Gross margin
43.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
Orasure Technologies Inc Q1 FY2026 Earnings Call
Positive tone
FDA submissions and product launches
International Diagnostics and near-shoring
Gross margin expansion
Revenue
$27.93M
▼ 6.7% YoY Diluted EPS
$-0.32
Gross margin
42.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-25
Orasure Technologies Inc Q4 FY2025 Earnings Call
Positive tone
Product pipeline and FDA submissions
International expansion and nearshoring
BiMedomics / Sickle SCAN integration
Revenue
$26.76M*
▼ 28.5% YoY Gross margin
41.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Orasure Technologies Inc Q3 FY2025 Earnings Call
Balanced tone
BioMedomics acquisition and Sickle SCAN
Financial guidance and cost discipline
Innovation pipeline and Sherlock platform
Revenue
$27.09M
▼ 32.1% YoY Diluted EPS
$-0.19
Gross margin
43.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Orasure Technologies Inc Q2 FY2025 Earnings Call
Balanced tone
HEMAcollect PROTEIN product launch
Sample Management / consumer genetics customer
Together Take Me Home federal program
Revenue
$31.24M
▼ 42.5% YoY Diluted EPS
$-0.26
Gross margin
42.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Orasure Technologies Inc Q1 FY2025 Earnings Call
Balanced tone
Public health funding and aid disruption (PEPFAR/USAID/NIH)
Together Take Me Home program
Capital deployment: share repurchase and M&A
Revenue
$29.93M
▼ 44.7% YoY Diluted EPS
$-0.21
Gross margin
41.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
Orasure Technologies Inc Q4 FY2024 Earnings Call
Balanced tone
International diagnostics / donor funding uncertainty
Core revenue growth
NIH research funding risk
Revenue
$37.45M*
▼ 50.7% YoY Gross margin
36.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-06
Orasure Technologies Inc Q3 FY2024 Earnings Call
Positive tone
Operating efficiency and gross margin expansion
Proteomics / Blood sample management launch
International / WHO prequalification
Revenue
$39.91M
▼ 55.2% YoY Diluted EPS
$-0.06
▼ 140% YoY Gross margin
42.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Orasure Technologies Inc Q2 FY2024 Earnings Call
Positive tone
Gross margin headwinds and diversification
Core revenue and guidance
COVID-19 / InteliSwab contract completion
Revenue
$54.34M
▼ 36.4% YoY Diluted EPS
$-0.01
Gross margin
45.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
Orasure Technologies Inc Q1 FY2024 Earnings Call
Positive tone
Restructuring and cost reduction
Balance sheet and cash flow
Strategic partnerships
Revenue
$54.13M
▼ 65.1% YoY Diluted EPS
$-0.05
▼ 113.5% YoY Gross margin
44.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Orasure Technologies Inc Q4 FY2023 Earnings Call
Positive tone
Distribution partnerships and portfolio expansion
HIV and sexual health
COVID-19 / InteliSwab
Revenue
$75.88M*
▼ 38.3% YoY Gross margin
46.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Orasure Technologies Inc Q3 FY2023 Earnings Call
Revenue
$89.19M
▼ 23.4% YoY Diluted EPS
$0.15
▲ 87.5% YoY Gross margin
49.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Orasure Technologies Inc Q2 FY2023 Earnings Call
Revenue
$85.44M
▲ 6.5% YoY Diluted EPS
$-0.07
Gross margin
30.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
Orasure Technologies Inc Q1 FY2023 Earnings Call
Revenue
$154.96M
▲ 128.9% YoY Diluted EPS
$0.37
Gross margin
42.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-14
Orasure Technologies Inc Q4 FY2022 Earnings Call
Revenue
$123.08M*
▲ 93.6% YoY Gross margin
40.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Orasure Technologies Inc Q3 FY2022 Earnings Call
Revenue
$116.46M
▲ 116% YoY Diluted EPS
$0.08
Gross margin
39.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Orasure Technologies Inc Q2 FY2022 Earnings Call
Revenue
$80.23M
▲ 39.3% YoY Diluted EPS
$-0.26
Gross margin
34.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Orasure Technologies Inc Q1 FY2022 Earnings Call
Revenue
$67.71M
▲ 15.6% YoY Diluted EPS
$-0.28
▼ 660% YoY Gross margin
35.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Orasure Technologies Inc Q4 FY2021 Earnings Call
Revenue
$63.57M*
▲ 1.1% YoY Gross margin
42.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-03
Orasure Technologies Inc Q3 FY2021 Earnings Call
Revenue
$53.92M
▲ 12.3% YoY Diluted EPS
$-0.21
▼ 2200% YoY Gross margin
39.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-03
Orasure Technologies Inc Q2 FY2021 Earnings Call
Revenue
$57.61M
▲ 96.9% YoY Diluted EPS
$-0.02
Gross margin
53.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Orasure Technologies Inc Q1 FY2021 Earnings Call
Revenue
$58.58M
▲ 85.4% YoY Diluted EPS
$0.05
Gross margin
65.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-01
Orasure Technologies Inc Q4 FY2020 Earnings Call
Revenue
$62.85M*
▲ 26.6% YoY Gross margin
60.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-04
Orasure Technologies Inc Q3 FY2020 Earnings Call
Revenue
$48.01M
▲ 33.4% YoY Diluted EPS
$0.01
▼ 95.2% YoY Gross margin
63.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
Orasure Technologies Inc Q2 FY2020 Earnings Call
Revenue
$29.26M
▼ 24.6% YoY Diluted EPS
$-0.16
▼ 328.6% YoY Gross margin
59.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Orasure Technologies Inc Q1 FY2020 Earnings Call
Revenue
$31.60M
▲ 4.9% YoY Diluted EPS
$-0.12
Gross margin
51.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-19
Orasure Technologies Inc Q4 FY2019 Earnings Call
Revenue
$49.67M
▼ 1.2% YoY Diluted EPS
$0.04
▼ 75% YoY Gross margin
60.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls